Heliyon-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2215181, encodeId=53812215181d1, content=各位好人，二审的一个审稿人审了8天了，这个有时间限制么，审这么久有点慌张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202407/2dc648729b9b4703a362533fee4f0d73-5S3Jxdpcjd7y.jpg, createdBy=b8829129489, createdName=接收吧！, createdTime=Tue Jul 16 09:02:12 CST 2024, time=2024-07-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2209608, encodeId=36eb220960842, content=6.4号rrc了，至今官网还是under review，大家有这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jun 13 08:42:59 CST 2024, time=2024-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180373, encodeId=e6ed21803e360, content=审稿速度:3.0 经验分享：投了一篇case 23年11月30日接收的，还没让交版面费，这是啥情况呀，谢谢各位大哥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Tue Jan 09 21:54:29 CST 2024, time=2024-01-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191664, encodeId=b3cc21916640b, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：代谢产物;微生物 经验分享：文章已经online了，但是没看到在哪缴费啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fb8437793, createdName=ms7000001652113176, createdTime=Thu Mar 07 09:45:11 CST 2024, time=2024-03-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215620, encodeId=9612221562056, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：使用编辑推荐的润色服务 经验分享：本人三月份投过一篇临床类研究，1个半月外审结束，三个审稿人，意见不多且容易回复，但都没有提出要润色，大修。编辑提出11个问题，有的问题很低级，感觉不熟悉临床研究，润色是强制要求！本人认真回复，且AJE润色，没有使用他推荐的（价格和时间问题）。返修后，令人恶心的事情发生了，编辑竟然又选了14个审稿人，从新进行审稿，1个多月后，拒稿！意见里面竟然还有英文不行需要润色。多次邮件询问原因，说是二审14个审稿人中有一个是一审里面的，觉得审稿意见不充分所以添加新的。本人作为审稿人同时间帮该杂志审了一篇稿子，客套话让我多投次杂志！无耻至极！高度怀疑改杂志社（编辑）和润色公司有返利协议，专剥削非英语国家（中国）的作者。当时急于在6月底发表才投了这个杂志，目前该杂志名声快赶上几大水刊了！请大家考虑！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fed71709963, createdName=松子8939, createdTime=Thu Jul 18 16:21:51 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212067, encodeId=dda7221206e80, content=偏重的研究方向：生信+临床 经验分享：请问各位大佬，heliyon的二审有时间期限吗？二审回去后，审稿人一直没有接收审稿，系统是8天发邮件催一次审稿人，会不会审稿人长时间不接收审稿，编辑就拒稿呢？审稿意见很简单，只有一个小问题，但是每天都很焦虑/(ㄒoㄒ)/~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe905532976, createdName=ms2000001991982419, createdTime=Fri Jun 28 11:19:11 CST 2024, time=2024-06-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2214509, encodeId=3153221450993, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：癌症;生信 经验分享：2023年6月7号投稿，现已经13个月了，还没外审完，心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a9d8174633, createdName=ms3000000971888026, createdTime=Thu Jul 11 21:17:33 CST 2024, time=2024-07-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2214452, encodeId=1091221445253, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：3月投的，刚接收，生信＋临床验证。等待第1轮审稿等了将近2个月，后面审稿较快，2个审稿人，意见较好，2轮3轮审稿在编辑部内部审查了，7月10号已接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Thu Jul 11 13:22:19 CST 2024, time=2024-07-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2213343, encodeId=af822213343da, content=投稿命中率:5.0 经验分享：投了为啥收不到邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5074952347, createdName=zhumedical, createdTime=Fri Jul 05 00:24:14 CST 2024, time=2024-07-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213976, encodeId=d41b22139e6d6, content=偏重的研究方向：生信;临床 经验分享：辣鸡得很，审稿巨慢，而且审稿意见和稿件不相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d9147174, createdName=ms5000002126430453, createdTime=Mon Jul 08 18:19:22 CST 2024, time=2024-07-08, status=1, ipAttribution=重庆)]

2024-07-16 接收吧！来自陕西省

各位好人，二审的一个审稿人审了8天了，这个有时间限制么，审这么久有点慌张

31 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2215181, encodeId=53812215181d1, content=各位好人，二审的一个审稿人审了8天了，这个有时间限制么，审这么久有点慌张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202407/2dc648729b9b4703a362533fee4f0d73-5S3Jxdpcjd7y.jpg, createdBy=b8829129489, createdName=接收吧！, createdTime=Tue Jul 16 09:02:12 CST 2024, time=2024-07-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2209608, encodeId=36eb220960842, content=6.4号rrc了，至今官网还是under review，大家有这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jun 13 08:42:59 CST 2024, time=2024-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180373, encodeId=e6ed21803e360, content=审稿速度:3.0 经验分享：投了一篇case 23年11月30日接收的，还没让交版面费，这是啥情况呀，谢谢各位大哥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Tue Jan 09 21:54:29 CST 2024, time=2024-01-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191664, encodeId=b3cc21916640b, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：代谢产物;微生物 经验分享：文章已经online了，但是没看到在哪缴费啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fb8437793, createdName=ms7000001652113176, createdTime=Thu Mar 07 09:45:11 CST 2024, time=2024-03-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215620, encodeId=9612221562056, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：使用编辑推荐的润色服务 经验分享：本人三月份投过一篇临床类研究，1个半月外审结束，三个审稿人，意见不多且容易回复，但都没有提出要润色，大修。编辑提出11个问题，有的问题很低级，感觉不熟悉临床研究，润色是强制要求！本人认真回复，且AJE润色，没有使用他推荐的（价格和时间问题）。返修后，令人恶心的事情发生了，编辑竟然又选了14个审稿人，从新进行审稿，1个多月后，拒稿！意见里面竟然还有英文不行需要润色。多次邮件询问原因，说是二审14个审稿人中有一个是一审里面的，觉得审稿意见不充分所以添加新的。本人作为审稿人同时间帮该杂志审了一篇稿子，客套话让我多投次杂志！无耻至极！高度怀疑改杂志社（编辑）和润色公司有返利协议，专剥削非英语国家（中国）的作者。当时急于在6月底发表才投了这个杂志，目前该杂志名声快赶上几大水刊了！请大家考虑！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fed71709963, createdName=松子8939, createdTime=Thu Jul 18 16:21:51 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212067, encodeId=dda7221206e80, content=偏重的研究方向：生信+临床 经验分享：请问各位大佬，heliyon的二审有时间期限吗？二审回去后，审稿人一直没有接收审稿，系统是8天发邮件催一次审稿人，会不会审稿人长时间不接收审稿，编辑就拒稿呢？审稿意见很简单，只有一个小问题，但是每天都很焦虑/(ㄒoㄒ)/~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe905532976, createdName=ms2000001991982419, createdTime=Fri Jun 28 11:19:11 CST 2024, time=2024-06-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2214509, encodeId=3153221450993, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：癌症;生信 经验分享：2023年6月7号投稿，现已经13个月了，还没外审完，心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a9d8174633, createdName=ms3000000971888026, createdTime=Thu Jul 11 21:17:33 CST 2024, time=2024-07-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2214452, encodeId=1091221445253, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：3月投的，刚接收，生信＋临床验证。等待第1轮审稿等了将近2个月，后面审稿较快，2个审稿人，意见较好，2轮3轮审稿在编辑部内部审查了，7月10号已接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Thu Jul 11 13:22:19 CST 2024, time=2024-07-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2213343, encodeId=af822213343da, content=投稿命中率:5.0 经验分享：投了为啥收不到邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5074952347, createdName=zhumedical, createdTime=Fri Jul 05 00:24:14 CST 2024, time=2024-07-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213976, encodeId=d41b22139e6d6, content=偏重的研究方向：生信;临床 经验分享：辣鸡得很，审稿巨慢，而且审稿意见和稿件不相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d9147174, createdName=ms5000002126430453, createdTime=Mon Jul 08 18:19:22 CST 2024, time=2024-07-08, status=1, ipAttribution=重庆)]

2024-06-13 国统乃我辈之愿

6.4号rrc了，至今官网还是under review，大家有这种情况吗？

22 32

展开32条回复

[GetPortalCommentsPageByObjectIdResponse(id=2215181, encodeId=53812215181d1, content=各位好人，二审的一个审稿人审了8天了，这个有时间限制么，审这么久有点慌张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202407/2dc648729b9b4703a362533fee4f0d73-5S3Jxdpcjd7y.jpg, createdBy=b8829129489, createdName=接收吧！, createdTime=Tue Jul 16 09:02:12 CST 2024, time=2024-07-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2209608, encodeId=36eb220960842, content=6.4号rrc了，至今官网还是under review，大家有这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jun 13 08:42:59 CST 2024, time=2024-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180373, encodeId=e6ed21803e360, content=审稿速度:3.0 经验分享：投了一篇case 23年11月30日接收的，还没让交版面费，这是啥情况呀，谢谢各位大哥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Tue Jan 09 21:54:29 CST 2024, time=2024-01-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191664, encodeId=b3cc21916640b, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：代谢产物;微生物 经验分享：文章已经online了，但是没看到在哪缴费啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fb8437793, createdName=ms7000001652113176, createdTime=Thu Mar 07 09:45:11 CST 2024, time=2024-03-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215620, encodeId=9612221562056, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：使用编辑推荐的润色服务 经验分享：本人三月份投过一篇临床类研究，1个半月外审结束，三个审稿人，意见不多且容易回复，但都没有提出要润色，大修。编辑提出11个问题，有的问题很低级，感觉不熟悉临床研究，润色是强制要求！本人认真回复，且AJE润色，没有使用他推荐的（价格和时间问题）。返修后，令人恶心的事情发生了，编辑竟然又选了14个审稿人，从新进行审稿，1个多月后，拒稿！意见里面竟然还有英文不行需要润色。多次邮件询问原因，说是二审14个审稿人中有一个是一审里面的，觉得审稿意见不充分所以添加新的。本人作为审稿人同时间帮该杂志审了一篇稿子，客套话让我多投次杂志！无耻至极！高度怀疑改杂志社（编辑）和润色公司有返利协议，专剥削非英语国家（中国）的作者。当时急于在6月底发表才投了这个杂志，目前该杂志名声快赶上几大水刊了！请大家考虑！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fed71709963, createdName=松子8939, createdTime=Thu Jul 18 16:21:51 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212067, encodeId=dda7221206e80, content=偏重的研究方向：生信+临床 经验分享：请问各位大佬，heliyon的二审有时间期限吗？二审回去后，审稿人一直没有接收审稿，系统是8天发邮件催一次审稿人，会不会审稿人长时间不接收审稿，编辑就拒稿呢？审稿意见很简单，只有一个小问题，但是每天都很焦虑/(ㄒoㄒ)/~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe905532976, createdName=ms2000001991982419, createdTime=Fri Jun 28 11:19:11 CST 2024, time=2024-06-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2214509, encodeId=3153221450993, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：癌症;生信 经验分享：2023年6月7号投稿，现已经13个月了，还没外审完，心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a9d8174633, createdName=ms3000000971888026, createdTime=Thu Jul 11 21:17:33 CST 2024, time=2024-07-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2214452, encodeId=1091221445253, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：3月投的，刚接收，生信＋临床验证。等待第1轮审稿等了将近2个月，后面审稿较快，2个审稿人，意见较好，2轮3轮审稿在编辑部内部审查了，7月10号已接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Thu Jul 11 13:22:19 CST 2024, time=2024-07-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2213343, encodeId=af822213343da, content=投稿命中率:5.0 经验分享：投了为啥收不到邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5074952347, createdName=zhumedical, createdTime=Fri Jul 05 00:24:14 CST 2024, time=2024-07-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213976, encodeId=d41b22139e6d6, content=偏重的研究方向：生信;临床 经验分享：辣鸡得很，审稿巨慢，而且审稿意见和稿件不相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d9147174, createdName=ms5000002126430453, createdTime=Mon Jul 08 18:19:22 CST 2024, time=2024-07-08, status=1, ipAttribution=重庆)]

2024-01-09 ms6000001563747786 来自江西省

审稿速度:3.0
经验分享：投了一篇case 23年11月30日接收的，还没让交版面费，这是啥情况呀，谢谢各位大哥

68 20

展开20条回复

[GetPortalCommentsPageByObjectIdResponse(id=2215181, encodeId=53812215181d1, content=各位好人，二审的一个审稿人审了8天了，这个有时间限制么，审这么久有点慌张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202407/2dc648729b9b4703a362533fee4f0d73-5S3Jxdpcjd7y.jpg, createdBy=b8829129489, createdName=接收吧！, createdTime=Tue Jul 16 09:02:12 CST 2024, time=2024-07-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2209608, encodeId=36eb220960842, content=6.4号rrc了，至今官网还是under review，大家有这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jun 13 08:42:59 CST 2024, time=2024-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180373, encodeId=e6ed21803e360, content=审稿速度:3.0 经验分享：投了一篇case 23年11月30日接收的，还没让交版面费，这是啥情况呀，谢谢各位大哥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Tue Jan 09 21:54:29 CST 2024, time=2024-01-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191664, encodeId=b3cc21916640b, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：代谢产物;微生物 经验分享：文章已经online了，但是没看到在哪缴费啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fb8437793, createdName=ms7000001652113176, createdTime=Thu Mar 07 09:45:11 CST 2024, time=2024-03-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215620, encodeId=9612221562056, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：使用编辑推荐的润色服务 经验分享：本人三月份投过一篇临床类研究，1个半月外审结束，三个审稿人，意见不多且容易回复，但都没有提出要润色，大修。编辑提出11个问题，有的问题很低级，感觉不熟悉临床研究，润色是强制要求！本人认真回复，且AJE润色，没有使用他推荐的（价格和时间问题）。返修后，令人恶心的事情发生了，编辑竟然又选了14个审稿人，从新进行审稿，1个多月后，拒稿！意见里面竟然还有英文不行需要润色。多次邮件询问原因，说是二审14个审稿人中有一个是一审里面的，觉得审稿意见不充分所以添加新的。本人作为审稿人同时间帮该杂志审了一篇稿子，客套话让我多投次杂志！无耻至极！高度怀疑改杂志社（编辑）和润色公司有返利协议，专剥削非英语国家（中国）的作者。当时急于在6月底发表才投了这个杂志，目前该杂志名声快赶上几大水刊了！请大家考虑！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fed71709963, createdName=松子8939, createdTime=Thu Jul 18 16:21:51 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212067, encodeId=dda7221206e80, content=偏重的研究方向：生信+临床 经验分享：请问各位大佬，heliyon的二审有时间期限吗？二审回去后，审稿人一直没有接收审稿，系统是8天发邮件催一次审稿人，会不会审稿人长时间不接收审稿，编辑就拒稿呢？审稿意见很简单，只有一个小问题，但是每天都很焦虑/(ㄒoㄒ)/~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe905532976, createdName=ms2000001991982419, createdTime=Fri Jun 28 11:19:11 CST 2024, time=2024-06-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2214509, encodeId=3153221450993, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：癌症;生信 经验分享：2023年6月7号投稿，现已经13个月了，还没外审完，心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a9d8174633, createdName=ms3000000971888026, createdTime=Thu Jul 11 21:17:33 CST 2024, time=2024-07-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2214452, encodeId=1091221445253, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：3月投的，刚接收，生信＋临床验证。等待第1轮审稿等了将近2个月，后面审稿较快，2个审稿人，意见较好，2轮3轮审稿在编辑部内部审查了，7月10号已接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Thu Jul 11 13:22:19 CST 2024, time=2024-07-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2213343, encodeId=af822213343da, content=投稿命中率:5.0 经验分享：投了为啥收不到邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5074952347, createdName=zhumedical, createdTime=Fri Jul 05 00:24:14 CST 2024, time=2024-07-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213976, encodeId=d41b22139e6d6, content=偏重的研究方向：生信;临床 经验分享：辣鸡得很，审稿巨慢，而且审稿意见和稿件不相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d9147174, createdName=ms5000002126430453, createdTime=Mon Jul 08 18:19:22 CST 2024, time=2024-07-08, status=1, ipAttribution=重庆)]

2024-03-07 ms7000001652113176 来自安徽省

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：代谢产物;微生物
经验分享：文章已经online了，但是没看到在哪缴费啊

63 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2215181, encodeId=53812215181d1, content=各位好人，二审的一个审稿人审了8天了，这个有时间限制么，审这么久有点慌张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202407/2dc648729b9b4703a362533fee4f0d73-5S3Jxdpcjd7y.jpg, createdBy=b8829129489, createdName=接收吧！, createdTime=Tue Jul 16 09:02:12 CST 2024, time=2024-07-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2209608, encodeId=36eb220960842, content=6.4号rrc了，至今官网还是under review，大家有这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jun 13 08:42:59 CST 2024, time=2024-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180373, encodeId=e6ed21803e360, content=审稿速度:3.0 经验分享：投了一篇case 23年11月30日接收的，还没让交版面费，这是啥情况呀，谢谢各位大哥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Tue Jan 09 21:54:29 CST 2024, time=2024-01-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191664, encodeId=b3cc21916640b, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：代谢产物;微生物 经验分享：文章已经online了，但是没看到在哪缴费啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fb8437793, createdName=ms7000001652113176, createdTime=Thu Mar 07 09:45:11 CST 2024, time=2024-03-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215620, encodeId=9612221562056, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：使用编辑推荐的润色服务 经验分享：本人三月份投过一篇临床类研究，1个半月外审结束，三个审稿人，意见不多且容易回复，但都没有提出要润色，大修。编辑提出11个问题，有的问题很低级，感觉不熟悉临床研究，润色是强制要求！本人认真回复，且AJE润色，没有使用他推荐的（价格和时间问题）。返修后，令人恶心的事情发生了，编辑竟然又选了14个审稿人，从新进行审稿，1个多月后，拒稿！意见里面竟然还有英文不行需要润色。多次邮件询问原因，说是二审14个审稿人中有一个是一审里面的，觉得审稿意见不充分所以添加新的。本人作为审稿人同时间帮该杂志审了一篇稿子，客套话让我多投次杂志！无耻至极！高度怀疑改杂志社（编辑）和润色公司有返利协议，专剥削非英语国家（中国）的作者。当时急于在6月底发表才投了这个杂志，目前该杂志名声快赶上几大水刊了！请大家考虑！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fed71709963, createdName=松子8939, createdTime=Thu Jul 18 16:21:51 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212067, encodeId=dda7221206e80, content=偏重的研究方向：生信+临床 经验分享：请问各位大佬，heliyon的二审有时间期限吗？二审回去后，审稿人一直没有接收审稿，系统是8天发邮件催一次审稿人，会不会审稿人长时间不接收审稿，编辑就拒稿呢？审稿意见很简单，只有一个小问题，但是每天都很焦虑/(ㄒoㄒ)/~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe905532976, createdName=ms2000001991982419, createdTime=Fri Jun 28 11:19:11 CST 2024, time=2024-06-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2214509, encodeId=3153221450993, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：癌症;生信 经验分享：2023年6月7号投稿，现已经13个月了，还没外审完，心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a9d8174633, createdName=ms3000000971888026, createdTime=Thu Jul 11 21:17:33 CST 2024, time=2024-07-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2214452, encodeId=1091221445253, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：3月投的，刚接收，生信＋临床验证。等待第1轮审稿等了将近2个月，后面审稿较快，2个审稿人，意见较好，2轮3轮审稿在编辑部内部审查了，7月10号已接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Thu Jul 11 13:22:19 CST 2024, time=2024-07-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2213343, encodeId=af822213343da, content=投稿命中率:5.0 经验分享：投了为啥收不到邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5074952347, createdName=zhumedical, createdTime=Fri Jul 05 00:24:14 CST 2024, time=2024-07-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213976, encodeId=d41b22139e6d6, content=偏重的研究方向：生信;临床 经验分享：辣鸡得很，审稿巨慢，而且审稿意见和稿件不相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d9147174, createdName=ms5000002126430453, createdTime=Mon Jul 08 18:19:22 CST 2024, time=2024-07-08, status=1, ipAttribution=重庆)]

2024-07-18 松子8939 来自江苏省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：使用编辑推荐的润色服务
经验分享：本人三月份投过一篇临床类研究，1个半月外审结束，三个审稿人，意见不多且容易回复，但都没有提出要润色，大修。编辑提出11个问题，有的问题很低级，感觉不熟悉临床研究，润色是强制要求！本人认真回复，且AJE润色，没有使用他推荐的（价格和时间问题）。返修后，令人恶心的事情发生了，编辑竟然又选了14个审稿人，从新进行审稿，1个多月后，拒稿！意见里面竟然还有英文不行需要润色。多次邮件询问原因，说是二审14个审稿人中有一个是一审里面的，觉得审稿意见不充分所以添加新的。本人作为审稿人同时间帮该杂志审了一篇稿子，客套话让我多投次杂志！无耻至极！高度怀疑改杂志社（编辑）和润色公司有返利协议，专剥削非英语国家（中国）的作者。当时急于在6月底发表才投了这个杂志，目前该杂志名声快赶上几大水刊了！请大家考虑！

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2215181, encodeId=53812215181d1, content=各位好人，二审的一个审稿人审了8天了，这个有时间限制么，审这么久有点慌张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202407/2dc648729b9b4703a362533fee4f0d73-5S3Jxdpcjd7y.jpg, createdBy=b8829129489, createdName=接收吧！, createdTime=Tue Jul 16 09:02:12 CST 2024, time=2024-07-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2209608, encodeId=36eb220960842, content=6.4号rrc了，至今官网还是under review，大家有这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jun 13 08:42:59 CST 2024, time=2024-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180373, encodeId=e6ed21803e360, content=审稿速度:3.0 经验分享：投了一篇case 23年11月30日接收的，还没让交版面费，这是啥情况呀，谢谢各位大哥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Tue Jan 09 21:54:29 CST 2024, time=2024-01-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191664, encodeId=b3cc21916640b, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：代谢产物;微生物 经验分享：文章已经online了，但是没看到在哪缴费啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fb8437793, createdName=ms7000001652113176, createdTime=Thu Mar 07 09:45:11 CST 2024, time=2024-03-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215620, encodeId=9612221562056, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：使用编辑推荐的润色服务 经验分享：本人三月份投过一篇临床类研究，1个半月外审结束，三个审稿人，意见不多且容易回复，但都没有提出要润色，大修。编辑提出11个问题，有的问题很低级，感觉不熟悉临床研究，润色是强制要求！本人认真回复，且AJE润色，没有使用他推荐的（价格和时间问题）。返修后，令人恶心的事情发生了，编辑竟然又选了14个审稿人，从新进行审稿，1个多月后，拒稿！意见里面竟然还有英文不行需要润色。多次邮件询问原因，说是二审14个审稿人中有一个是一审里面的，觉得审稿意见不充分所以添加新的。本人作为审稿人同时间帮该杂志审了一篇稿子，客套话让我多投次杂志！无耻至极！高度怀疑改杂志社（编辑）和润色公司有返利协议，专剥削非英语国家（中国）的作者。当时急于在6月底发表才投了这个杂志，目前该杂志名声快赶上几大水刊了！请大家考虑！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fed71709963, createdName=松子8939, createdTime=Thu Jul 18 16:21:51 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212067, encodeId=dda7221206e80, content=偏重的研究方向：生信+临床 经验分享：请问各位大佬，heliyon的二审有时间期限吗？二审回去后，审稿人一直没有接收审稿，系统是8天发邮件催一次审稿人，会不会审稿人长时间不接收审稿，编辑就拒稿呢？审稿意见很简单，只有一个小问题，但是每天都很焦虑/(ㄒoㄒ)/~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe905532976, createdName=ms2000001991982419, createdTime=Fri Jun 28 11:19:11 CST 2024, time=2024-06-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2214509, encodeId=3153221450993, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：癌症;生信 经验分享：2023年6月7号投稿，现已经13个月了，还没外审完，心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a9d8174633, createdName=ms3000000971888026, createdTime=Thu Jul 11 21:17:33 CST 2024, time=2024-07-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2214452, encodeId=1091221445253, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：3月投的，刚接收，生信＋临床验证。等待第1轮审稿等了将近2个月，后面审稿较快，2个审稿人，意见较好，2轮3轮审稿在编辑部内部审查了，7月10号已接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Thu Jul 11 13:22:19 CST 2024, time=2024-07-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2213343, encodeId=af822213343da, content=投稿命中率:5.0 经验分享：投了为啥收不到邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5074952347, createdName=zhumedical, createdTime=Fri Jul 05 00:24:14 CST 2024, time=2024-07-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213976, encodeId=d41b22139e6d6, content=偏重的研究方向：生信;临床 经验分享：辣鸡得很，审稿巨慢，而且审稿意见和稿件不相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d9147174, createdName=ms5000002126430453, createdTime=Mon Jul 08 18:19:22 CST 2024, time=2024-07-08, status=1, ipAttribution=重庆)]

2024-06-28 ms2000001991982419 来自广东省

偏重的研究方向：生信+临床
经验分享：请问各位大佬，heliyon的二审有时间期限吗？二审回去后，审稿人一直没有接收审稿，系统是8天发邮件催一次审稿人，会不会审稿人长时间不接收审稿，编辑就拒稿呢？审稿意见很简单，只有一个小问题，但是每天都很焦虑/(ㄒoㄒ)/~~

17 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=2215181, encodeId=53812215181d1, content=各位好人，二审的一个审稿人审了8天了，这个有时间限制么，审这么久有点慌张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202407/2dc648729b9b4703a362533fee4f0d73-5S3Jxdpcjd7y.jpg, createdBy=b8829129489, createdName=接收吧！, createdTime=Tue Jul 16 09:02:12 CST 2024, time=2024-07-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2209608, encodeId=36eb220960842, content=6.4号rrc了，至今官网还是under review，大家有这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jun 13 08:42:59 CST 2024, time=2024-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180373, encodeId=e6ed21803e360, content=审稿速度:3.0 经验分享：投了一篇case 23年11月30日接收的，还没让交版面费，这是啥情况呀，谢谢各位大哥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Tue Jan 09 21:54:29 CST 2024, time=2024-01-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191664, encodeId=b3cc21916640b, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：代谢产物;微生物 经验分享：文章已经online了，但是没看到在哪缴费啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fb8437793, createdName=ms7000001652113176, createdTime=Thu Mar 07 09:45:11 CST 2024, time=2024-03-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215620, encodeId=9612221562056, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：使用编辑推荐的润色服务 经验分享：本人三月份投过一篇临床类研究，1个半月外审结束，三个审稿人，意见不多且容易回复，但都没有提出要润色，大修。编辑提出11个问题，有的问题很低级，感觉不熟悉临床研究，润色是强制要求！本人认真回复，且AJE润色，没有使用他推荐的（价格和时间问题）。返修后，令人恶心的事情发生了，编辑竟然又选了14个审稿人，从新进行审稿，1个多月后，拒稿！意见里面竟然还有英文不行需要润色。多次邮件询问原因，说是二审14个审稿人中有一个是一审里面的，觉得审稿意见不充分所以添加新的。本人作为审稿人同时间帮该杂志审了一篇稿子，客套话让我多投次杂志！无耻至极！高度怀疑改杂志社（编辑）和润色公司有返利协议，专剥削非英语国家（中国）的作者。当时急于在6月底发表才投了这个杂志，目前该杂志名声快赶上几大水刊了！请大家考虑！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fed71709963, createdName=松子8939, createdTime=Thu Jul 18 16:21:51 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212067, encodeId=dda7221206e80, content=偏重的研究方向：生信+临床 经验分享：请问各位大佬，heliyon的二审有时间期限吗？二审回去后，审稿人一直没有接收审稿，系统是8天发邮件催一次审稿人，会不会审稿人长时间不接收审稿，编辑就拒稿呢？审稿意见很简单，只有一个小问题，但是每天都很焦虑/(ㄒoㄒ)/~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe905532976, createdName=ms2000001991982419, createdTime=Fri Jun 28 11:19:11 CST 2024, time=2024-06-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2214509, encodeId=3153221450993, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：癌症;生信 经验分享：2023年6月7号投稿，现已经13个月了，还没外审完，心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a9d8174633, createdName=ms3000000971888026, createdTime=Thu Jul 11 21:17:33 CST 2024, time=2024-07-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2214452, encodeId=1091221445253, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：3月投的，刚接收，生信＋临床验证。等待第1轮审稿等了将近2个月，后面审稿较快，2个审稿人，意见较好，2轮3轮审稿在编辑部内部审查了，7月10号已接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Thu Jul 11 13:22:19 CST 2024, time=2024-07-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2213343, encodeId=af822213343da, content=投稿命中率:5.0 经验分享：投了为啥收不到邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5074952347, createdName=zhumedical, createdTime=Fri Jul 05 00:24:14 CST 2024, time=2024-07-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213976, encodeId=d41b22139e6d6, content=偏重的研究方向：生信;临床 经验分享：辣鸡得很，审稿巨慢，而且审稿意见和稿件不相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d9147174, createdName=ms5000002126430453, createdTime=Mon Jul 08 18:19:22 CST 2024, time=2024-07-08, status=1, ipAttribution=重庆)]

2024-07-11 ms3000000971888026 来自山西省

审稿速度:24.0 | 投稿命中率:50.0
偏重的研究方向：癌症;生信
经验分享：2023年6月7号投稿，现已经13个月了，还没外审完，心累。

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2215181, encodeId=53812215181d1, content=各位好人，二审的一个审稿人审了8天了，这个有时间限制么，审这么久有点慌张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202407/2dc648729b9b4703a362533fee4f0d73-5S3Jxdpcjd7y.jpg, createdBy=b8829129489, createdName=接收吧！, createdTime=Tue Jul 16 09:02:12 CST 2024, time=2024-07-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2209608, encodeId=36eb220960842, content=6.4号rrc了，至今官网还是under review，大家有这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jun 13 08:42:59 CST 2024, time=2024-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180373, encodeId=e6ed21803e360, content=审稿速度:3.0 经验分享：投了一篇case 23年11月30日接收的，还没让交版面费，这是啥情况呀，谢谢各位大哥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Tue Jan 09 21:54:29 CST 2024, time=2024-01-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191664, encodeId=b3cc21916640b, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：代谢产物;微生物 经验分享：文章已经online了，但是没看到在哪缴费啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fb8437793, createdName=ms7000001652113176, createdTime=Thu Mar 07 09:45:11 CST 2024, time=2024-03-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215620, encodeId=9612221562056, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：使用编辑推荐的润色服务 经验分享：本人三月份投过一篇临床类研究，1个半月外审结束，三个审稿人，意见不多且容易回复，但都没有提出要润色，大修。编辑提出11个问题，有的问题很低级，感觉不熟悉临床研究，润色是强制要求！本人认真回复，且AJE润色，没有使用他推荐的（价格和时间问题）。返修后，令人恶心的事情发生了，编辑竟然又选了14个审稿人，从新进行审稿，1个多月后，拒稿！意见里面竟然还有英文不行需要润色。多次邮件询问原因，说是二审14个审稿人中有一个是一审里面的，觉得审稿意见不充分所以添加新的。本人作为审稿人同时间帮该杂志审了一篇稿子，客套话让我多投次杂志！无耻至极！高度怀疑改杂志社（编辑）和润色公司有返利协议，专剥削非英语国家（中国）的作者。当时急于在6月底发表才投了这个杂志，目前该杂志名声快赶上几大水刊了！请大家考虑！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fed71709963, createdName=松子8939, createdTime=Thu Jul 18 16:21:51 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212067, encodeId=dda7221206e80, content=偏重的研究方向：生信+临床 经验分享：请问各位大佬，heliyon的二审有时间期限吗？二审回去后，审稿人一直没有接收审稿，系统是8天发邮件催一次审稿人，会不会审稿人长时间不接收审稿，编辑就拒稿呢？审稿意见很简单，只有一个小问题，但是每天都很焦虑/(ㄒoㄒ)/~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe905532976, createdName=ms2000001991982419, createdTime=Fri Jun 28 11:19:11 CST 2024, time=2024-06-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2214509, encodeId=3153221450993, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：癌症;生信 经验分享：2023年6月7号投稿，现已经13个月了，还没外审完，心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a9d8174633, createdName=ms3000000971888026, createdTime=Thu Jul 11 21:17:33 CST 2024, time=2024-07-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2214452, encodeId=1091221445253, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：3月投的，刚接收，生信＋临床验证。等待第1轮审稿等了将近2个月，后面审稿较快，2个审稿人，意见较好，2轮3轮审稿在编辑部内部审查了，7月10号已接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Thu Jul 11 13:22:19 CST 2024, time=2024-07-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2213343, encodeId=af822213343da, content=投稿命中率:5.0 经验分享：投了为啥收不到邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5074952347, createdName=zhumedical, createdTime=Fri Jul 05 00:24:14 CST 2024, time=2024-07-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213976, encodeId=d41b22139e6d6, content=偏重的研究方向：生信;临床 经验分享：辣鸡得很，审稿巨慢，而且审稿意见和稿件不相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d9147174, createdName=ms5000002126430453, createdTime=Mon Jul 08 18:19:22 CST 2024, time=2024-07-08, status=1, ipAttribution=重庆)]

2024-07-11 超超不吵吵来自湖南省

审稿速度:3.0 | 投稿命中率:75.0
经验分享：3月投的，刚接收，生信＋临床验证。等待第1轮审稿等了将近2个月，后面审稿较快，2个审稿人，意见较好，2轮3轮审稿在编辑部内部审查了，7月10号已接收。

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2215181, encodeId=53812215181d1, content=各位好人，二审的一个审稿人审了8天了，这个有时间限制么，审这么久有点慌张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202407/2dc648729b9b4703a362533fee4f0d73-5S3Jxdpcjd7y.jpg, createdBy=b8829129489, createdName=接收吧！, createdTime=Tue Jul 16 09:02:12 CST 2024, time=2024-07-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2209608, encodeId=36eb220960842, content=6.4号rrc了，至今官网还是under review，大家有这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jun 13 08:42:59 CST 2024, time=2024-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180373, encodeId=e6ed21803e360, content=审稿速度:3.0 经验分享：投了一篇case 23年11月30日接收的，还没让交版面费，这是啥情况呀，谢谢各位大哥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Tue Jan 09 21:54:29 CST 2024, time=2024-01-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191664, encodeId=b3cc21916640b, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：代谢产物;微生物 经验分享：文章已经online了，但是没看到在哪缴费啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fb8437793, createdName=ms7000001652113176, createdTime=Thu Mar 07 09:45:11 CST 2024, time=2024-03-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215620, encodeId=9612221562056, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：使用编辑推荐的润色服务 经验分享：本人三月份投过一篇临床类研究，1个半月外审结束，三个审稿人，意见不多且容易回复，但都没有提出要润色，大修。编辑提出11个问题，有的问题很低级，感觉不熟悉临床研究，润色是强制要求！本人认真回复，且AJE润色，没有使用他推荐的（价格和时间问题）。返修后，令人恶心的事情发生了，编辑竟然又选了14个审稿人，从新进行审稿，1个多月后，拒稿！意见里面竟然还有英文不行需要润色。多次邮件询问原因，说是二审14个审稿人中有一个是一审里面的，觉得审稿意见不充分所以添加新的。本人作为审稿人同时间帮该杂志审了一篇稿子，客套话让我多投次杂志！无耻至极！高度怀疑改杂志社（编辑）和润色公司有返利协议，专剥削非英语国家（中国）的作者。当时急于在6月底发表才投了这个杂志，目前该杂志名声快赶上几大水刊了！请大家考虑！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fed71709963, createdName=松子8939, createdTime=Thu Jul 18 16:21:51 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212067, encodeId=dda7221206e80, content=偏重的研究方向：生信+临床 经验分享：请问各位大佬，heliyon的二审有时间期限吗？二审回去后，审稿人一直没有接收审稿，系统是8天发邮件催一次审稿人，会不会审稿人长时间不接收审稿，编辑就拒稿呢？审稿意见很简单，只有一个小问题，但是每天都很焦虑/(ㄒoㄒ)/~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe905532976, createdName=ms2000001991982419, createdTime=Fri Jun 28 11:19:11 CST 2024, time=2024-06-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2214509, encodeId=3153221450993, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：癌症;生信 经验分享：2023年6月7号投稿，现已经13个月了，还没外审完，心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a9d8174633, createdName=ms3000000971888026, createdTime=Thu Jul 11 21:17:33 CST 2024, time=2024-07-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2214452, encodeId=1091221445253, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：3月投的，刚接收，生信＋临床验证。等待第1轮审稿等了将近2个月，后面审稿较快，2个审稿人，意见较好，2轮3轮审稿在编辑部内部审查了，7月10号已接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Thu Jul 11 13:22:19 CST 2024, time=2024-07-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2213343, encodeId=af822213343da, content=投稿命中率:5.0 经验分享：投了为啥收不到邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5074952347, createdName=zhumedical, createdTime=Fri Jul 05 00:24:14 CST 2024, time=2024-07-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213976, encodeId=d41b22139e6d6, content=偏重的研究方向：生信;临床 经验分享：辣鸡得很，审稿巨慢，而且审稿意见和稿件不相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d9147174, createdName=ms5000002126430453, createdTime=Mon Jul 08 18:19:22 CST 2024, time=2024-07-08, status=1, ipAttribution=重庆)]

2024-07-05 zhumedical 来自北京

投稿命中率:5.0
经验分享：投了为啥收不到邮件

21 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2215181, encodeId=53812215181d1, content=各位好人，二审的一个审稿人审了8天了，这个有时间限制么，审这么久有点慌张, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202407/2dc648729b9b4703a362533fee4f0d73-5S3Jxdpcjd7y.jpg, createdBy=b8829129489, createdName=接收吧！, createdTime=Tue Jul 16 09:02:12 CST 2024, time=2024-07-16, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2209608, encodeId=36eb220960842, content=6.4号rrc了，至今官网还是under review，大家有这种情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=32, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ae372438623, createdName=国统乃我辈之愿, createdTime=Thu Jun 13 08:42:59 CST 2024, time=2024-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2180373, encodeId=e6ed21803e360, content=审稿速度:3.0 经验分享：投了一篇case 23年11月30日接收的，还没让交版面费，这是啥情况呀，谢谢各位大哥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cf68540126, createdName=ms6000001563747786, createdTime=Tue Jan 09 21:54:29 CST 2024, time=2024-01-09, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2191664, encodeId=b3cc21916640b, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：代谢产物;微生物 经验分享：文章已经online了，但是没看到在哪缴费啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88fb8437793, createdName=ms7000001652113176, createdTime=Thu Mar 07 09:45:11 CST 2024, time=2024-03-07, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215620, encodeId=9612221562056, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：使用编辑推荐的润色服务 经验分享：本人三月份投过一篇临床类研究，1个半月外审结束，三个审稿人，意见不多且容易回复，但都没有提出要润色，大修。编辑提出11个问题，有的问题很低级，感觉不熟悉临床研究，润色是强制要求！本人认真回复，且AJE润色，没有使用他推荐的（价格和时间问题）。返修后，令人恶心的事情发生了，编辑竟然又选了14个审稿人，从新进行审稿，1个多月后，拒稿！意见里面竟然还有英文不行需要润色。多次邮件询问原因，说是二审14个审稿人中有一个是一审里面的，觉得审稿意见不充分所以添加新的。本人作为审稿人同时间帮该杂志审了一篇稿子，客套话让我多投次杂志！无耻至极！高度怀疑改杂志社（编辑）和润色公司有返利协议，专剥削非英语国家（中国）的作者。当时急于在6月底发表才投了这个杂志，目前该杂志名声快赶上几大水刊了！请大家考虑！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fed71709963, createdName=松子8939, createdTime=Thu Jul 18 16:21:51 CST 2024, time=2024-07-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2212067, encodeId=dda7221206e80, content=偏重的研究方向：生信+临床 经验分享：请问各位大佬，heliyon的二审有时间期限吗？二审回去后，审稿人一直没有接收审稿，系统是8天发邮件催一次审稿人，会不会审稿人长时间不接收审稿，编辑就拒稿呢？审稿意见很简单，只有一个小问题，但是每天都很焦虑/(ㄒoㄒ)/~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe905532976, createdName=ms2000001991982419, createdTime=Fri Jun 28 11:19:11 CST 2024, time=2024-06-28, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2214509, encodeId=3153221450993, content=审稿速度:24.0 | 投稿命中率:50.0 偏重的研究方向：癌症;生信 经验分享：2023年6月7号投稿，现已经13个月了，还没外审完，心累。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a9d8174633, createdName=ms3000000971888026, createdTime=Thu Jul 11 21:17:33 CST 2024, time=2024-07-11, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2214452, encodeId=1091221445253, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：3月投的，刚接收，生信＋临床验证。等待第1轮审稿等了将近2个月，后面审稿较快，2个审稿人，意见较好，2轮3轮审稿在编辑部内部审查了，7月10号已接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef635598785, createdName=超超不吵吵, createdTime=Thu Jul 11 13:22:19 CST 2024, time=2024-07-11, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2213343, encodeId=af822213343da, content=投稿命中率:5.0 经验分享：投了为啥收不到邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5074952347, createdName=zhumedical, createdTime=Fri Jul 05 00:24:14 CST 2024, time=2024-07-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2213976, encodeId=d41b22139e6d6, content=偏重的研究方向：生信;临床 经验分享：辣鸡得很，审稿巨慢，而且审稿意见和稿件不相关, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5d9147174, createdName=ms5000002126430453, createdTime=Mon Jul 08 18:19:22 CST 2024, time=2024-07-08, status=1, ipAttribution=重庆)]

2024-07-08 ms5000002126430453 来自重庆

偏重的研究方向：生信;临床
经验分享：辣鸡得很，审稿巨慢，而且审稿意见和稿件不相关

19 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务